Cargando…
Transcription factor EB agonists from natural products for treating human diseases with impaired autophagy-lysosome pathway
Autophagy is a highly conserved degradation process for long-lived intracellular proteins and organelles mediated by lysosomes. Deficits in the autophagy-lysosome pathway (ALP) have been linked to a variety of human diseases, including neurodegenerative diseases, lysosomal storage disorders, and can...
Autores principales: | Xu, Jie, Zhang, Xiao-Qi, Zhang, Zaijun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7684757/ https://www.ncbi.nlm.nih.gov/pubmed/33292395 http://dx.doi.org/10.1186/s13020-020-00402-1 |
Ejemplares similares
-
Harmol promotes α-synuclein degradation and improves motor impairment in Parkinson’s models via regulating autophagy-lysosome pathway
por: Xu, Jie, et al.
Publicado: (2022) -
Transcriptional regulation of autophagy‐lysosomal pathway in cancer
por: Chang, Xinzhong, et al.
Publicado: (2020) -
Amyloid β-Induced Redistribution of Transcriptional Factor EB and Lysosomal Dysfunction in Primary Microglial Cells
por: Guo, Xingzhi, et al.
Publicado: (2017) -
Sub-lethal oxidative stress induces lysosome biogenesis via a lysosomal membrane permeabilization-cathepsin-caspase 3-transcription factor EB-dependent pathway
por: Leow, San Min, et al.
Publicado: (2016) -
Suppression of lysosomal acid alpha‐glucosidase impacts the modulation of transcription factor EB translocation in pancreatic cancer
por: Hamura, Ryoga, et al.
Publicado: (2021)